Morgan Stanley
NMRA icon

Morgan Stanley’s Neumora Therapeutics NMRA Stock Holding History

Morgan Stanley’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$982K Buy
503,819
+265,335
+111% +$688K ﹤0.01% 5150
2025
Q4 		$427K Sell
238,484
-36,283
-13% -$79.4K ﹤0.01% 5586
2025
Q3 		$500K Buy
274,767
+46,129
+20% +$74.6K ﹤0.01% 5499
2025
Q2 		$168K Sell
228,638
-623,734
-73% -$473K ﹤0.01% 5919
2025
Q1 		$852K Buy
852,372
+120,960
+17% +$207K ﹤0.01% 5080
2024
Q4 		$7.75M Buy
731,412
+377,721
+107% +$4.53M ﹤0.01% 3619
2024
Q3 		$4.67M Buy
353,691
+196,953
+126% +$2.3M ﹤0.01% 4011
2024
Q2 		$1.54M Buy
156,738
+91,363
+140% +$945K ﹤0.01% 4719
2024
Q1 		$899K Buy
65,375
+3,217
+5% +$52K ﹤0.01% 5016
2023
Q4 		$1.06M Buy
62,158
+61,758
+15,440% +$758K ﹤0.01% 5263
2023
Q3 		$5.64K Buy
+400
New +$5K ﹤0.01% 6885

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return